Zealand Pharma A/S Return on Tangible Equity 2018-2022 | ZEAL
Current and historical return on tangible equity values for Zealand Pharma A/S (ZEAL) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2022-03-31 | $-0.16B | $0.11B | -97.97% |
| 2021-12-31 | $-0.16B | $0.14B | -81.61% |
| 2021-09-30 | $-0.18B | $0.18B | -85.27% |
| 2021-06-30 | $-0.18B | $0.22B | -81.43% |
| 2021-03-31 | $-0.14B | $0.26B | -60.98% |
| 2020-12-31 | $-0.13B | $0.18B | -61.14% |
| 2020-09-30 | $-0.10B | $0.24B | -46.81% |
| 2020-06-30 | $-0.08B | $0.26B | -39.28% |
| 2020-03-31 | $-0.09B | $0.18B | -52.15% |
| 2019-12-31 | $-0.09B | $0.19B | -48.66% |
| 2019-09-30 | $-0.07B | $0.21B | -42.35% |
| 2019-06-30 | $0.09B | $0.15B | 50.95% |
| 2019-03-31 | $0.09B | $0.17B | 59.86% |
| 2018-12-31 | $0.09B | $0.18B | 74.34% |
| 2018-09-30 | $0.09B | $0.19B | 92.70% |
| 2018-06-30 | $-0.06B | $0.05B | -77.63% |
| 2018-03-31 | $-0.05B | $0.07B | -75.71% |
| 2017-12-31 | $-0.04B | $0.08B | -68.85% |
